Albendazole-induced granulomatous hepatitis: A case report

Journal of Medical Case Reports

Volumn 7, Issue , 2013, Pages

  Marin Zuluaga, Juan Ignacio ^a   Marin Castro, Andres Eduardo ^a   Perez Cadavid, Juan Camilo ^a   Restrepo Gutierrez, Juan Carlos ^a  

^a HOSPITAL PABLO TOBÓN URIBE   (Colombia)

Author keywords

Albendazole; Drug induced liver injury; Granulomatous hepatitis; Idiosyncratic hepatotoxicity

Indexed keywords

ALBENDAZOLE; PARACETAMOL; SCOPOLAMINE BUTYL BROMIDE;

ACUTE HEPATITIS; ADULT; ARTICLE; ASCARIASIS; BIOCHEMISTRY; CASE REPORT; DISEASE ASSOCIATION; FATIGUE; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; GRANULOMATOUS HEPATITIS; HELMINTHIASIS; HISPANIC; HUMAN; INFLAMMATORY INFILTRATE; JAUNDICE; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER NECROSIS; LIVER SINUSOID; LIVER TOXICITY; LYMPHOCYTIC INFILTRATION; MEDICAL HISTORY; NATIONAL HEALTH ORGANIZATION; NEUTROPHIL CHEMOTAXIS; PATIENT MONITORING; PRIORITY JOURNAL; TOXIC HEPATITIS; VOMITING; WEAKNESS;

EID: 84880875237     PISSN: None     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-7-201     Document Type: Article

References (13)

1. Granulomatous diseases of the liver. Sharma S, Hepatology: A Textbook of Liver Disease Philadelphia: Saunders/Elsevier, Zakim D, Boyer TD, 5 2006 767 780
2. Granulomatous hepatitis due to mebendazole. Colle I, Naegels S, Hoorens A, Hautekeete M, J Clin Gastroenterol 1999 28 1 44 45 10.1097/00004836- 199901000-00010 9916665 (Pubitemid 29011593)
3. Drug-induced liver injury: a clinical update. Ghabril M, Chalasani N, Bjornsson E, Curr Opin Gastroenterol 2010 26 3 222 226 10.1097/MOG. 0b013e3283383c7c 20186054
4. Causality assessment of adverse reactions to drugs. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. Danan G, Benichou C, J Clin Epidemiol 1993 46 1323 1330 10.1016/0895-4356(93)90101-6 8229110 (Pubitemid 23333873)
5. Idiosyncratic drug-induced liver injury: an overview. Hussaini SH, Farrington EA, Expert Opin Drug Saf 2007 6 6 673 684 10.1517/14740338.6.6.673 17967156 (Pubitemid 351308279)
6. Criteria of drug-induced liver disorders. Report of an international consensus meeting. Benichou C, J Hepatology 1990 11 2 272 276
7. Clinical evaluation of drug-induced hepatitis. Martí L, Del Olmo JA, Tosca J, Ornia E, García-Torres ML, Serra MA, Rodríguez F, Lluch P, Escudero A, Rodrigo JM, Rev Esp Enferm Dig 2005 97 4 258 265 15982181 (Pubitemid 40755661)
8. Randomized comparative trial of two high-dose albendazole regimens for uncomplicated human strongyloidiasis. Singthong S, Intapan PM, Wongsaroji T, Maleewong W, Southeast Asian J Trop Med Public Health 2006 37 Suppl 3 32 34 17547048
9. Antibiotic-induced liver toxicity: Mechanisms, clinical features and causality assessment. Robles M, Toscano E, Cotta J, Lucena MI, Andrade RJ, Curr Drug Saf 2010 3 212 222
10. Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry. Andrade RJ, Lucena MI, Kaplowitz N, Garcia-Munoz B, Borraz Y, Pachkoria K, García-Cortés M, Fernández MC, Pelaez G, Rodrigo L, Durán JA, Costa J, Planas R, Barriocanal A, Guarner C, Romero-Gomez M, Muņoz-Yagüe T, Salmerón J, Hidalgo R, Hepatology 2006 44 6 1581 1588 10.1002/hep.21424 17133470 (Pubitemid 44953663)
11. Recurrent hepatic toxicity secondary to intravenous methylprednisolone. Fernandez MR, Riesco JM, Moreira VF, Moreno A, San Roman AL, Arranz G, Ruiz Del Arbol L, Rev Esp Enferm Dig 2008 100 11 720 723 19159178
12. Acute drug-induced hepatitis caused by albendazole. Choi GY, Yang HW, Cho SH, Kang DW, Go H, Lee WC, Lee YJ, Jung SH, Kim AN, Cha SW, J Korean Med Sci 2008 23 5 903 905 10.3346/jkms.2008.23.5.903 18955802
13. Acute hepatitis as a side effect of albendazole: a pediatric case [abstract]. Amoruso C, Fuoti M, Miceli V, Zito E, Celano MR, De Giorgi A, Nebbia G, Pediatr Med Chir 2009 31 6 262 264 20333886